Abridge 发表于 2025-3-21 18:52:38

书目名称Experimental and Clinical Progress in Cancer Chemotherapy影响因子(影响力)<br>        http://figure.impactfactor.cn/if/?ISSN=BK0318964<br><br>        <br><br>书目名称Experimental and Clinical Progress in Cancer Chemotherapy影响因子(影响力)学科排名<br>        http://figure.impactfactor.cn/ifr/?ISSN=BK0318964<br><br>        <br><br>书目名称Experimental and Clinical Progress in Cancer Chemotherapy网络公开度<br>        http://figure.impactfactor.cn/at/?ISSN=BK0318964<br><br>        <br><br>书目名称Experimental and Clinical Progress in Cancer Chemotherapy网络公开度学科排名<br>        http://figure.impactfactor.cn/atr/?ISSN=BK0318964<br><br>        <br><br>书目名称Experimental and Clinical Progress in Cancer Chemotherapy被引频次<br>        http://figure.impactfactor.cn/tc/?ISSN=BK0318964<br><br>        <br><br>书目名称Experimental and Clinical Progress in Cancer Chemotherapy被引频次学科排名<br>        http://figure.impactfactor.cn/tcr/?ISSN=BK0318964<br><br>        <br><br>书目名称Experimental and Clinical Progress in Cancer Chemotherapy年度引用<br>        http://figure.impactfactor.cn/ii/?ISSN=BK0318964<br><br>        <br><br>书目名称Experimental and Clinical Progress in Cancer Chemotherapy年度引用学科排名<br>        http://figure.impactfactor.cn/iir/?ISSN=BK0318964<br><br>        <br><br>书目名称Experimental and Clinical Progress in Cancer Chemotherapy读者反馈<br>        http://figure.impactfactor.cn/5y/?ISSN=BK0318964<br><br>        <br><br>书目名称Experimental and Clinical Progress in Cancer Chemotherapy读者反馈学科排名<br>        http://figure.impactfactor.cn/5yr/?ISSN=BK0318964<br><br>        <br><br>

征兵 发表于 2025-3-21 23:02:47

Chemotherapy in Osteosarcoma: Advances and Controversies,ablished disease. These developments, however, have not been without controversy . The latter emerged principally from a comparison of the results of the new investigations with historical controls. This communication will outline the impact of chemotherapy in osteosarcoma and examine the controversial issues.

Valves 发表于 2025-3-22 03:24:10

http://reply.papertrans.cn/32/3190/318964/318964_3.png

circumvent 发表于 2025-3-22 07:41:56

https://doi.org/10.1007/978-3-642-86867-2enous thiols does not interfere with the immunosuppressive (i.e. myelosuppressive) and carcinostatic properties of CP, which appear to be the consequence of metabolism-dependent formation of the alkylating metabolites of CP, presumably phosphoramide mustard.

轮流 发表于 2025-3-22 11:38:17

http://reply.papertrans.cn/32/3190/318964/318964_5.png

bromide 发表于 2025-3-22 15:53:03

0927-3042 odels; drug classes; and clinical settings. Topics were chosen because of their timeliness or probable current impact in cancer treatment. Authors were selected on the basis of their ability to provide a critical overview of specific subjects and their involvement in original work. I shall review th

bromide 发表于 2025-3-22 19:08:01

http://reply.papertrans.cn/32/3190/318964/318964_7.png

绝种 发表于 2025-3-23 00:50:54

http://reply.papertrans.cn/32/3190/318964/318964_8.png

Musket 发表于 2025-3-23 02:55:39

http://reply.papertrans.cn/32/3190/318964/318964_9.png

cacophony 发表于 2025-3-23 08:16:59

Book 1985g classes; and clinical settings. Topics were chosen because of their timeliness or probable current impact in cancer treatment. Authors were selected on the basis of their ability to provide a critical overview of specific subjects and their involvement in original work. I shall review the aims of
页: [1] 2 3 4 5
查看完整版本: Titlebook: Experimental and Clinical Progress in Cancer Chemotherapy; Franco M. Muggia (Clinical Director) Book 1985 Martinus Nijhoff Publishers, Bos